Recent advances in the development of melanocortin-4 receptor ligands

By Nozawa Dai   Chaki Shigeyuki   Nakazato Atsuro  

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 4, 2008-04 ,pp. : 403-427

Informa Healthcare

Access to resources Recommend Favorite

Editorial [Hot Topic: Therapeutic Application of Melanocortin-4 Receptor Ligands (Guest Editor: John P. Mayer)]

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 11, 2007-06 ,pp. : 1120-1120

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in the Development of Melanocortin Receptor Selective Ligands

By  

Current Pharmaceutical Design, Vol. 10, Iss. 28, 2004-01 ,pp. : 3443-3479

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis of Piperazinephen-1-ylethylamines as Potent and Selective Antagonists of the Human Melanocortin-4 Receptor

By  

Letters in Drug Design & Discovery, Vol. 3, Iss. 5, 2006-07 ,pp. : 311-315

Bentham Science Publishers

Access to resources Recommend Favorite

Small Molecule CXCR4 Chemokine Receptor Antagonists: Developing Drug Candidates

By  

Current Medicinal Chemistry, Vol. 14, Iss. 21, 2007-09 ,pp. : 2257-2277

Bentham Science Publishers

Access to resources Recommend Favorite